findmyKOL

Richard Drake, MD

Basic profile

Gynecologic Oncology

ORCIDNone on fileNPI
RegionThe Woodlands, TX · South CentralSpecialtyGynecologic OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPayments2021 onwardNIH funding1990–1998Why? →

Richard Drake is an Oncology physician.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
27companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
3NIH grants · 1990–1998

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

17350 St Lukes Way Ste 350
The Woodlands, TX 773844103

Telephone

281-203-5115

Registry record last updated 28 Mar 2019.

View the NPPES registry record

Industry payments

27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    34.5%
    Nonsteroidal Anti-inflammatory Drug34.5%
    Ibuprofen100%
    Part D44 patients
  • Respiratory

    33.3%
    Opioid Agonist33.3%
    Hydrocodone-Acetaminophen100%
    Part D54 patients
  • Metabolism & gastrointestinal

    13.1%
    Serotonin-3 Receptor Antagonist13.1%
    Ondansetron Odt50%Ondansetron Hcl50%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

3 NIH research awards on record, funded 19901998 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”